tradingkey.logo
tradingkey.logo
Search

InspireMD Inc

NSPR
Add to Watchlist
0.751USD
-0.008-1.05%
Close 09-23 16:00ET
35.18MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.05%

5 Days

-2.47%

1 Month

-16.56%

6 Months

-56.84%

Year to Date

-57.81%

1 Year

-68.71%

Key Figures

0.750Open
0.770High
0.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
0.759Prev. Close
0.735Low
0.00Turnover
LossP/E Static
1.14P/B
0.00%Div Yield TTM
-107.86%ROA
2.56552wk High
0.70Volume Ratio
-32.01MNet Profit
46.84MShares
-0.6984EPS TTM
0.75Beta
-142.60%ROE
0.63052wk Low
7.33%Amplitude
-43.70%Gross Margin
35.18MMarket Cap
9.92Reward/Risk
3.92%Risk Rate
Recent
Transcripts
More news coming soon, stay tuned...

InspireMD Inc's Score

-0.04vs previous score
Forecast8.00
Financial Health5.88
Technical4.26
Valuation Dimensions8.38
Institutional Confidence3.00
Risk Assessment3.03

Media Coverage

Coverage Level

Very Low
Very High
Negative-

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
3.333Target Price
+339.23%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy00000000
Buy33333332
Hold00000000
Sell00000000
Strong Sell00000000

InspireMD Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

InspireMD Inc Latest Earnings Call Transcripts

InspireMD (NSPR) Q2 2026 Earnings Call: Recall Impact and FDA Catalysts

InspireMD Q2 2026 revenue was $1.8 million as recall charges pressured margins. International sales rose 21%, with key FDA decisions targeted for Q4.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.17/-0.20
Revenue / Forecast
1.77M/1.38M

InspireMD Inc Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolNSPR
Number of employees85
CountryUnited States of America

Ownership

ShareholdersProportion
Rosalind Advisors, Inc.8.34%
Nantahala Capital Management, LLC7.21%
abrdn Inc.6.78%
OrbiMed Advisors, LLC6.69%
Shareholder TypesProportion
Hedge Fund24.88%
Individual Investor20.36%
Investment Advisor/Hedge Fund16.50%
Private Equity6.69%

FAQs

What is the current price of InspireMD Inc (NSPR)?

The current price of InspireMD Inc (NSPR) is 0.75.

What is the symbol of InspireMD Inc?

The ticker symbol of InspireMD Inc is NSPR.

What is the 52-week high of InspireMD Inc?

The 52-week high of InspireMD Inc is 2.56.

What is the 52-week low of InspireMD Inc?

The 52-week low of InspireMD Inc is 0.63.

What is the market capitalization of InspireMD Inc?

The market capitalization of InspireMD Inc is 35.18M.

Is InspireMD Inc (NSPR) currently rated as Buy, Hold, or Sell?

According to analysts, InspireMD Inc (NSPR) has an overall rating of Buy, with a price target of 3.33.

What is the Earnings Per Share (EPS TTM) of InspireMD Inc (NSPR)?

The Earnings Per Share (EPS TTM) of InspireMD Inc (NSPR) is -0.70.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.